EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Propionate reinforces epithelial identity and reduces aggressiveness of lung carcinoma

Vignesh Ramesh, Paradesi Naidu Gollavilli, Luisa Pinna, Mohammad Aarif Siddiqui, Adriana Martinez Turtos iD, Francesca Napoli, Yasmin Antonelli, Aldo Leal-Egaña iD, Jesper Foged Havelund iD, Simon Toftholm Jakobsen iD, Elisa Le Boiteux, Marco Volante und 5 weitere

EMBO Molecular Medicine · 07.12.2023 · 15 (12)

DOI: 10.15252/emmm.202317836 ↗

Kurz gefasst

Fachartikel in der Zeitschrift EMBO Molecular Medicine, online erschienen am 28.09.2023. Verfasst von Vignesh Ramesh und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Danish Cancer Society, Deutsche Forschungsgemeinschaft (DFG), Interdisciplinary Center for Clinical Research of the University of Erlangen-Nuremberg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The epithelial‐to‐mesenchymal transition (EMT) plays a central role in the development of cancer metastasis and resistance to chemotherapy. However, its pharmacological treatment remains challenging. Here, we used an EMT‐focused integrative functional genomic approach and identified an inverse association between short‐chain fatty acids (propionate and butanoate) and EMT in non‐small cell lung cancer (NSCLC) patients. Remarkably, treatment with propionate in vitro reinforced the epithelial transcriptional program promoting cell‐to‐cell contact and cell adhesion, while reducing the aggressive and chemo‐resistant EMT phenotype in lung cancer cell lines. Propionate treatment also decreased the metastatic potential and limited lymph node spread in both nude mice and a genetic NSCLC mouse model. Further analysis revealed that chromatin remodeling through H3K27 acetylation (mediated by p300) is the mechanism underlying the shift toward an epithelial state upon propionate treatment. The results suggest that propionate administration has therapeutic potential in reducing NSCLC aggressiveness and warrants further clinical testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsCarcinoma, Non-Small-Cell LungHumansAnimalsMicePropionatesMice, NudeCell Line, TumorLungEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticCell Movement

Stichwörter der Autor:innen

H3K27 acetylationepithelial-mesenchymal transitionmetabolic inhibitormetastasispropionate

Substanzen

Propionates

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark.
  • Interdisciplinary Centre for Clinical Research, University Hospital Erlangen, FAU-Erlangen-Nuremberg, Erlangen, Germany.
  • Department of Oncology at San Luigi Hospital, University of Turin, Turin, Italy.
  • Institute for Molecular Systems Engineering and Advanced Materials, Heidelberg University, Heidelberg, Germany.

ORCID-Profile: Adriana Martinez Turtos, Aldo Leal-Egaña, Jesper Foged Havelund, Simon Toftholm Jakobsen, Nils Joakim Faergeman, Ole N Jensen, Rasmus Siersbaek, Paolo Ceppi

Förderung

  • Danish Cancer Society
  • Deutsche Forschungsgemeinschaft (DFG)
  • Interdisciplinary Center for Clinical Research of the University of Erlangen-Nuremberg
  • Lundbeck Foundation (Lundbeckfonden)
  • Novo Nordisk Foundation
  • Villum Foundation
  • Interdisciplinary Center for Clinical Research of the University of Erlangen‐Nuremberg

Zitieren

APA

Ramesh, V., Gollavilli, P. N., Pinna, L., Siddiqui, M. A., Turtos, A. M., Napoli, F., Antonelli, Y., Leal-Egaña, A., Havelund, J. F., Jakobsen, S. T., Boiteux, E. L., Volante, M., Faergeman, N. J., Jensen, O. N., Siersbaek, R., Somyajit, K., & Ceppi, P. (2023). Propionate reinforces epithelial identity and reduces aggressiveness of lung carcinoma. EMBO Molecular Medicine, 15(12). https://doi.org/10.15252/emmm.202317836

Vancouver

Ramesh V, Gollavilli PN, Pinna L, Siddiqui MA, Turtos AM, Napoli F, et al. Propionate reinforces epithelial identity and reduces aggressiveness of lung carcinoma. EMBO Molecular Medicine. 2023;15(12). doi:10.15252/emmm.202317836

BibTeX
@article{Ramesh2023,
  author = {Ramesh, Vignesh and Gollavilli, Paradesi Naidu and Pinna, Luisa and Siddiqui, Mohammad Aarif and Turtos, Adriana Martinez and Napoli, Francesca and Antonelli, Yasmin and Leal-Egaña, Aldo and Havelund, Jesper Foged and Jakobsen, Simon Toftholm and Boiteux, Elisa Le and Volante, Marco and Faergeman, Nils Joakim and Jensen, Ole N and Siersbaek, Rasmus and Somyajit, Kumar and Ceppi, Paolo},
  title = {Propionate reinforces epithelial identity and reduces aggressiveness of lung carcinoma},
  journal = {EMBO Molecular Medicine},
  year = {2023},
  volume = {15},
  number = {12},
  doi = {10.15252/emmm.202317836}
}
Kostenlos starten →